a client is receiving the cell cycle–nonspecific alkylating agent thiotepa (thioplex), 60 mg weekly for 4 weeks by bladder instillation as part of chemotherapy regimen to treat bladder cancer. the client asks the nurse how the drug works. how does thiotepa exert its therapeutic effects?